Amer­i­can Can­cer So­ci­ety leans on phar­ma part­ners for eq­ui­ty, pa­tient care and screen­ing col­lab­o­ra­tions

3 years ago
Pharma
Marketing

Scor­pi­on scores $65M as it lines up a part­ner to take EGFR pro­grams glob­al

3 years ago
Deals

As mar­ket stays cold, biotechs con­tin­ue to cut pro­grams, tri­als and staff

3 years ago
People
R&D

Gink­go sells Zymer­gen lab to chem­i­cal and ma­te­r­i­al man­u­fac­tur­er Solvay

3 years ago
Deals

ADC biotech brings to­tal Se­ries A raise to $89M+; Take­da hands $40M mile­stone to Ar­row­head

3 years ago
News Briefing

Bio­gen ap­points Adam Keeney to run busi­ness de­vel­op­ment ac­tiv­i­ties

3 years ago
People

OnKure Ther­a­peu­tics nabs $60M as HDAC in­hibitor awaits sol­id-tu­mor read­outs

3 years ago
Financing
Startups

Seagen, Mer­ck­'s Pad­cev-Keytru­da com­bo snags FDA ac­cel­er­at­ed ap­proval for blad­der can­cer

3 years ago
Pharma
FDA+

On­coSec re­ports flop for IL-12/Keytru­da com­bo in what may be fi­nal blow

3 years ago
R&D

The ‘new, old kids’ on the biotech block un­veil a $350M stealth sci­ence fund. And they’re go­ing very, very ...

3 years ago
Deals
Bioregnum

Ex­clu­sive: On­col­o­gy start­up from Sanger In­sti­tute nabs $28M, ex-No­var­tis SVP as CEO

3 years ago
Financing
Startups

Mi­to­chon­dria biotech field grows as RA, In­sight up the Ca­pac­i­ty with a new $35M start­up

3 years ago
Financing
Startups

Two pa­tient deaths lead to FDA par­tial hold for Gos­samer tri­al of lym­phoma drug

3 years ago
R&D
FDA+

More than half of ac­cel­er­at­ed ap­proval con­fir­ma­to­ry tri­als are late, re­searchers write in JA­MA

3 years ago
Pharma
FDA+

J&J spin­out los­es bid to de­lay talc bank­rupt­cy case as it heads to Supreme Court

3 years ago
Pharma
Law

Phar­ma fees to Eu­ro­pean reg­u­la­tor spike thanks to 10% in­fla­tion rate

3 years ago
FDA+

Gink­go part­ners up with Sen­si­ble Biotech­nolo­gies to forge mR­NA man­u­fac­tur­ing plat­form

3 years ago
Deals
Manufacturing

Sur­vey says drug com­mer­cial­iza­tion should stretch back, in­cor­po­rate dig­i­tal in­sights for doc­tors

3 years ago
Pharma

San­doz to pay Al­ler­gan, Duke Uni­ver­si­ty $39M over eye drug law­suit, ju­ry says

3 years ago
Pharma
Law

FDA re­veals clean­ing and test­ing is­sues at Glob­al Phar­ma In­di­an man­u­fac­tur­ing site

3 years ago
Pharma
FDA+

Phar­ma faces rip­ple ef­fects from fed­er­al court's cut­ting of pre­ven­tive care

3 years ago
Law

Biotech launched dur­ing Covid — for Covid — looks for strate­gic al­ter­na­tives af­ter an­tivi­ral fails PhII tri­al

3 years ago
R&D
Coronavirus

Ver­tex and CRISPR send exa-cel for FDA ap­proval; Aridis Ther­a­peu­tics ax­es 20% of its work­force

3 years ago
News Briefing

FDA cites ‘de­fi­cien­cies’ in As­cendis’ ap­pli­ca­tion for parathy­roid drug, jeop­ar­diz­ing po­ten­tial ap­proval

3 years ago
FDA+
First page Previous page 363364365366367368369 Next page Last page
A service from the Financial Times